National Spinal Cord Injury Statistical Center: Spinal cord injury: facts and figures at a glance.
J Spinal Cord Med 2005, 28:379–380.
Miniño AM: Death in the United States, 2009. NCHS data brief, no. 64. National Center for Health Statistics, Hyattsville, MD; 2011. http://www.cdc.gov/nchs/data/databriefs/db64.pdf
van den Berg ME, Castellote JM, de Pedro-Cuesta J, Mahillo-Fernandez I: Survival after spinal cord injury: a systematic review.
J Neurotrauma 2010, 27:1517–1528.
Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC: The cellular inflammatory response in human spinal cords after injury.
Brain: J Neurol 2006, 129:3249–3269.
Leal-Filho MB: Spinal cord injury: from inflammation to glial scar.
Surg Neurol Int 2011, 2:112.
Yang L, Jones NR, Blumbergs PC, Van Den Heuvel C, Moore EJ, Manavis J, Sarvestani GT, Ghabriel MN: Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat.
J Clin Neurosci 2005, 12:276–284.
Blight AR: Macrophages and inflammatory damage in spinal cord injury.
J Neurotrauma 1992,9(Suppl. 1):S83-S91.
Pruss H, Kopp MA, Brommer B, Gatzemeier N, Laginha I, Dirnagl U, Schwab JM: Non-Resolving Aspects of Acute Inflammation after Spinal Cord Injury (SCI): Indices and Resolution Plateau.
Brain Pathol 2011, 21:652–660.
Cohen DM, Patel CB, Ahobila-Vajjula P, Sundberg LM, Chacko T, Liu SJ, Narayana PA: Blood-spinal cord barrier permeability in experimental spinal cord injury: dynamic contrast-enhanced MRI.
NMR Biomed 2009, 22:332–341.
Ankeny DP, Popovich PG: Mechanisms and implications of adaptive immune responses after traumatic spinal cord injury.
Neuroscience 2009, 158:1112–1121.
Fehlings MG, Hawryluk GW: Scarring after spinal cord injury.
J Neurosurg Spine 2010, 13:165–167. discussion 167–168
Silver J, Miller JH: Regeneration beyond the glial scar.
Nat Rev Neurosci 2004, 5:146–156.
Gensel JC, Donnelly DJ, Popovich PG: Spinal cord injury therapies in humans: an overview of current clinical trials and their potential effects on intrinsic CNS macrophages.
Exp Opin Therapeutic Targets 2011, 15:505–518.
Kwon BK, Casha S, Hurlbert RJ, Yong VW: Inflammatory and structural biomarkers in acute traumatic spinal cord injury.
Clin Chem Lab Med: CCLM/FESCC 2011, 49:425–433.
Reiber H: Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases.
Mult Scler 1998, 4:99–107.
Lee N, Wong CK, Chan PK, Chan MC, Wong RY, Lun SW, Ngai KL, Lui GC, Wong BC, Lee SK, Choi KW, Hui DSC: Cytokine response patterns in severe pandemic 2009 H1N1 and seasonal influenza among hospitalized adults.
PLoS One 2011, 6:e26050.
Mizutani T, Akasaka R, Tomita K, Chiba T: Serial changes of cytokines in Crohn's disease treated with infliximab.
Tefferi A, Vaidya R, Caramazza D, Finke C, Lasho T, Pardanani A: Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study.
J Clin Oncol 2011, 29:1356–1363.
Nielsen UB, Geierstanger BH: Multiplexed sandwich assays in microarray format.
J Immunol Methods 2004, 290:107–120.
Pang S, Smith J, Onley D, Reeve J, Walker M, Foy C: A comparability study of the emerging protein array platforms with established ELISA procedures.
J Immunol Methods 2005, 302:1–12.
Benjamini Y, Hochburg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing.
J Royal Stat Soc Series B (Methodol) 1995, 57:289–300.
Hsueh HM, Chen JJ, Kodell RL: Comparison of methods for estimating the number of true null hypotheses in multiplicity testing.
J Biopharm Stat 2003, 13:675–689.
Zhao M, Wang X, Nolte D: Mass-transport limitations in spot-based microarrays.
Biomed Opt Express 2010, 1:983–997.
Streit WJ, Semple-Rowland SL, Hurley SD, Miller RC, Popovich PG, Stokes BT: Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis.
Exp Neurol 1998, 152:74–87.
Wang CX, Olschowka JA, Wrathall JR: Increase of interleukin-1beta mRNA and protein in the spinal cord following experimental traumatic injury in the rat.
Brain Res 1997, 759:190–196.
Kwon BK, Stammers AM, Belanger LM, Bernardo A, Chan D, Bishop CM, Slobogean GP, Zhang H, Umedaly H, Giffin M, Street J, Boyd MC, Paquette SJ, Fisher CG, Dvorak MF: Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury.
J Neurotrauma 2010, 27:669–682.
Lubieniecka JM, Streijger F, Lee JH, Stoynov N, Liu J, Mottus R, Pfeifer T, Kwon BK, Coorssen JR, Foster LJ, Grigliatti TA, Tetzlaff W: Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats.
PLoS One 2011, 6:e19247.
RayBiotech, Inchttp://www.raybiotech.com(November 12, 2011)
Team RDC: R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria; 2011.
Pinheiro J, Bates D, DebRoy S, Sarkar D, nlme: Linear and Nonlinear Mixed Effects Models. R package version 3.1–102 edition. R Foundation for Statistical Computing, Vienna, Austria; 2011.
Beck KD, Nguyen HX, Galvan MD, Salazar DL, Woodruff TM, Anderson AJ: Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment.
Brain 2010, 133:433–447.
De Castro RC, Burns CL, McAdoo DJ, Romanic AM: Metalloproteinase increases in the injured rat spinal cord.
NeuroReport 2000, 11:3551–3554.
Wells JE, Rice TK, Nuttall RK, Edwards DR, Zekki H, Rivest S, Yong VW: An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice.
J Neurosci 2003, 23:10107–10115.
Veeravalli KK, Dasari VR, Tsung AJ, Dinh DH, Gujrati M, Fassett D, Rao JS: Human umbilical cord blood stem cells upregulate matrix metalloproteinase-2 in rats after spinal cord injury.
Neurobiol Dis 2009, 36:200–212.
Leivonen SK, Chantry A, Hakkinen L, Han J, Kahari VM: Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signaling pathways.
J Biol Chem 2002, 277:46338–46346.
Kim ES, Kim MS, Moon A: TGF-beta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells.
Int J Oncol 2004, 25:1375–1382.
Cuadrado E, Rosell A, Penalba A, Slevin M, Alvarez-Sabin J, Ortega-Aznar A, Montaner J: Vascular MMP-9/TIMP-2 and neuronal MMP-10 up-regulation in human brain after stroke: a combined laser microdissection and protein array study.
J Proteome Res 2009, 8:3191–3197.